Autolus Therapeutics PLC Unit Enters Master Service Agreement With AGC Biologics

Reuters

Jan 27

Jan 26 (Reuters) - Autolus Therapeutics PLC <6A3Ay.F>::
*AUTOLUS THERAPEUTICS PLC - UNIT ENTERS MASTER SERVICE AGREEMENT WITH AGC BIOLOGICS - SEC FILING
*AUTOLUS THERAPEUTICS PLC: AGREEMENT FOR MANUFACTURE AND SUPPLY OF LENTIVIRAL VECTOR
*AUTOLUS THERAPEUTICS PLC - AGREEMENT RUNS FOR TEN YEARS, TERMINABLE FOR DEFAULT - SEC FILING
*AUTOLUS THERAPEUTICS PLC - UNDER DEAL, TO PURCHASE MINIMUM OF 14 BATCHES OF LENTIVIRAL VECTOR DURING FIRST 2 CALENDAR YEARS - SEC FILING
*AUTOLUS THERAPEUTICS PLC - TO PURCHASE MINIMUM EUR 25 MILLION OF PRODUCTS AND SERVICES - SEC FILING
*Further company coverage: [6A3Ay.F]
* ((Reuters.Briefs@thomsonreuters.com;))

((Reuters Investor Briefs; email: reutersinvestor.briefs@thomsonreuters.com))
Source Date/Time = 26-JAN-202621:07:00.093 GMT

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/news/2606229403"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"2606229403\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/2606229403?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-01-27 05:53","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2606229403","market":"nz","top_or_hot":-1,"title":"Autolus Therapeutics PLC Unit Enters Master Service Agreement With AGC Biologics","media":"Reuters","content":"<html><body>Jan 26 (Reuters) - <a href=\"https://laohu8.com/S/AUTL\">Autolus Therapeutics PLC</a> &lt;6A3Ay.F&gt;::<br/>*AUTOLUS THERAPEUTICS <a href=\"https://laohu8.com/S/PLC\">PLC</a> - UNIT ENTERS MASTER SERVICE AGREEMENT WITH AGC BIOLOGICS - SEC FILING<br/>*AUTOLUS THERAPEUTICS PLC: AGREEMENT FOR MANUFACTURE AND SUPPLY OF LENTIVIRAL VECTOR<br/>*AUTOLUS THERAPEUTICS PLC - AGREEMENT RUNS FOR TEN YEARS, TERMINABLE FOR DEFAULT - SEC FILING<br/>*AUTOLUS THERAPEUTICS PLC - UNDER DEAL, TO PURCHASE MINIMUM OF 14 BATCHES OF LENTIVIRAL VECTOR DURING FIRST 2 CALENDAR YEARS  - SEC FILING<br/>*AUTOLUS THERAPEUTICS PLC - TO PURCHASE MINIMUM EUR 25 MILLION OF PRODUCTS AND SERVICES - SEC FILING<br/>*Further company coverage: [6A3Ay.F]<br/>* ((Reuters.Briefs@thomsonreuters.com;))<br/><br/>  ((Reuters Investor Briefs; email: reutersinvestor.briefs@thomsonreuters.com))<br/>  Source Date/Time = 26-JAN-202621:07:00.093 GMT</body></html>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Autolus Therapeutics PLC Unit Enters Master Service Agreement With AGC Biologics</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nAutolus Therapeutics PLC Unit Enters Master Service Agreement With AGC Biologics\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1032215980\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/4567337cbdf294b657b1fa87c5488b48);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Reuters </p>\n<p class=\"h-time\">2026-01-27 05:53</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<html><body>Jan 26 (Reuters) - <a href=\"https://laohu8.com/S/AUTL\">Autolus Therapeutics PLC</a> &lt;6A3Ay.F&gt;::<br/>*AUTOLUS THERAPEUTICS <a href=\"https://laohu8.com/S/PLC\">PLC</a> - UNIT ENTERS MASTER SERVICE AGREEMENT WITH AGC BIOLOGICS - SEC FILING<br/>*AUTOLUS THERAPEUTICS PLC: AGREEMENT FOR MANUFACTURE AND SUPPLY OF LENTIVIRAL VECTOR<br/>*AUTOLUS THERAPEUTICS PLC - AGREEMENT RUNS FOR TEN YEARS, TERMINABLE FOR DEFAULT - SEC FILING<br/>*AUTOLUS THERAPEUTICS PLC - UNDER DEAL, TO PURCHASE MINIMUM OF 14 BATCHES OF LENTIVIRAL VECTOR DURING FIRST 2 CALENDAR YEARS  - SEC FILING<br/>*AUTOLUS THERAPEUTICS PLC - TO PURCHASE MINIMUM EUR 25 MILLION OF PRODUCTS AND SERVICES - SEC FILING<br/>*Further company coverage: [6A3Ay.F]<br/>* ((Reuters.Briefs@thomsonreuters.com;))<br/><br/>  ((Reuters Investor Briefs; email: reutersinvestor.briefs@thomsonreuters.com))<br/>  Source Date/Time = 26-JAN-202621:07:00.093 GMT</body></html>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"BK4139","symbol_name":"生物科技","start_time":0,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260126:nRSD8vNfH6:1","article_id":"2606229403","we_media_id":"1032215980","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2606229403","pubTimestamp":1769464410,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Reuters","introduction":"Reuters.com brings you the latest news from around the world, covering breaking news in markets, business, politics, entertainment and technology","home_visible":1,"id":"1032215980","head_image":"https://community-static.tradeup.com/news/4567337cbdf294b657b1fa87c5488b48"},"summary":"Jan 26 (Reuters) - Autolus Therapeutics PLC <6A3Ay.F>::*AUTOLUS THERAPEUTICS PLC - UNIT ENTERS MASTER SERVICE AGREEMENT WITH AGC BIOLOGICS - SEC FILING*AUTOLUS THERAPEUTICS PLC: AGREEMENT FOR MANUFACT","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"BK4139":"生物科技","LU2125909759.SGD":"Natixis Thematics Safety H-R/A SGD","LU1481600234.SGD":"THREADNEEDLE (LUX) UK EQUITY INCOME \"ASC\" (SGDHDG) INC","LU2125909916.SGD":"Natixis Thematics Safety R/A SGD","LU1273509221.SGD":"Fidelity European Dynamic Growth A-ACC-SGD (hedged)","LU1923622291.USD":"Natixis Thematics Safety R/A USD","LU2089284900.SGD":"Allianz Global Sustainability Cl AM Dis H2-SGD","LU1487256676.USD":"THREADNEEDLE (LUX) UK EQUITY INCOME \"ZUH\" (USDHDG) ACC","LU2271345857.HKD":"ALLIANZ GLOBAL SUSTAINABILITY \"AT\" (HKD) ACC","BK5061":"环境与设施服务","LU1196032939.SGD":"Fidelity European Dynamic Growth A-SGD","LU2023251221.USD":"ALLIANZ GLOBAL SUSTAINABILITY \"AM\" (USD) INC","LU2111349929.HKD":"ALLIANZ GLOBAL SUSTAINABILITY \"AM\" (HKD) INC","RTO.UK":"能多洁","LU0158827948.USD":"ALLIANZ GLOBAL SUSTAINABILITY \"A\" (USD) INC","LU2028103732.USD":"ALLIANZ GLOBAL SUSTAINABILITY \"AMG\" (USD) INC","LU0158827781.USD":" ALLIANZ GLOBAL SUSTAINABILITY \"AT\" (USD) ACC","LU1481599808.USD":"THREADNEEDLE (LUX) UK EQUITY INCOME \"AUC\" (USDHDG) INC","LU2089283258.USD":"安联环球可持续基金Cl AM Dis","AUTL":"Autolus Therapeutics PLC"},"translate_title":"Autolus Therapeutics PLC部门与AGC Biologics签订主服务协议","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"AUTL":0.9,"RTO.UK":0.9},"content_text":"Jan 26 (Reuters) - Autolus Therapeutics PLC <6A3Ay.F>::*AUTOLUS THERAPEUTICS PLC - UNIT ENTERS MASTER SERVICE AGREEMENT WITH AGC BIOLOGICS - SEC FILING*AUTOLUS THERAPEUTICS PLC: AGREEMENT FOR MANUFACTURE AND SUPPLY OF LENTIVIRAL VECTOR*AUTOLUS THERAPEUTICS PLC - AGREEMENT RUNS FOR TEN YEARS, TERMINABLE FOR DEFAULT - SEC FILING*AUTOLUS THERAPEUTICS PLC - UNDER DEAL, TO PURCHASE MINIMUM OF 14 BATCHES OF LENTIVIRAL VECTOR DURING FIRST 2 CALENDAR YEARS  - SEC FILING*AUTOLUS THERAPEUTICS PLC - TO PURCHASE MINIMUM EUR 25 MILLION OF PRODUCTS AND SERVICES - SEC FILING*Further company coverage: [6A3Ay.F]* ((Reuters.Briefs@thomsonreuters.com;))  ((Reuters Investor Briefs; email: reutersinvestor.briefs@thomsonreuters.com))  Source Date/Time = 26-JAN-202621:07:00.093 GMT","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"1","news_tag":"corporation","news_rank":0,"symbols":[],"gpt_button":1,"need_auth":false,"code":"91000000","status":"200"}}}